SGLT2 Inhibition

DRUG2 trials

Sponsors

Zhongshan Hospital Xiamen University, Kyungsub Song

Conditions

Diabetic NephropathyHeart FailureHeart Failure Due to Coronary Artery DiseaseType 2 DiabetesValvular Cardiomyopathy

Phase 4

Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes

Zhongshan Hospital Xiamen UniversityDiabetic Nephropathy, Type 2 Diabetes

Start: 2019-10-15End: 2021-08-31Target: 70Updated: 2019-10-21

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Not yet recruitingNCT07572032

Kyungsub SongHeart Failure, Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy

Start: 2026-05-20End: 2028-12-20Target: 80Updated: 2026-05-07

Related Papers

SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathway

Diabetology & Metabolic Syndrome2024-02-1614 citations

SGLT2 inhibitors attenuate nephrin loss and enhance TGF-β1 secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial

Scientific Reports2022-09-2022 citations